The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,034.00
Bid: 12,034.00
Ask: 12,038.00
Change: 6.00 (0.05%)
Spread: 4.00 (0.033%)
Open: 12,052.00
High: 12,094.00
Low: 12,018.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Stocks fall as virus cases rise; U.S. dollar edges higher

Mon, 04th Jan 2021 20:27

* U.S. stocks sharply lower in afternoon trading

* Gold prices rally

* U.S. bond prices fall
(Updates with closing oil prices)

By Caroline Valetkevitch

NEW YORK, Jan 4 (Reuters) - U.S. stocks dropped more than 1%
on Monday, the first trading day of the new year, pulling back
after recent gains to record highs, while the U.S. dollar was up
slightly.

Stocks hit record highs early in the session as investors
focused on the rollout of COVID-19 vaccines, but sentiment
quickly turned cautious over the path of the virus, which
continues to spread amid the discovery of a new variant.

The outcome of runoff elections on Tuesday in Georgia for
two U.S. Senate seats added to the nervousness.

"Investors are feeling a bit nervous on the first trading
day of the new year, and I think this is a confluence of
factors," said Lindsey Bell, chief investment strategist at Ally
Invest, in Charlotte, North Carolina.

MSCI's All-Country World Index, which tracks
stocks across 49 countries, was down 0.7% after earlier hitting
a record high.

The Dow Jones Industrial Average fell 492 points, or
1.61%, to 30,114.48, the S&P 500 lost 64.89 points, or
1.73%, to 3,691.18 and the Nasdaq Composite dropped
210.31 points, or 1.63%, to 12,677.98.

The pan-European STOXX 600 index rose 0.67%, while
Britain's FTSE 100 index closed up 1.7% on its first
post-Brexit trading day.

Britain began vaccinating its population with the COVID-19
shot developed by Oxford University and AstraZeneca on
Monday.

With the lag between a full vaccine rollout and a global
economic recovery, investors will count on central banks to keep
money cheap.

Minutes of the Federal Reserve's Dec. 15-16 policy meeting
are due on Wednesday and should offer more details on
discussions about making the U.S. central bank's forward policy
guidance more explicit and the chance of a further increase in
asset purchases this year.

Friday brings the U.S. employment report for December.

In currencies, the U.S. dollar recovered after falling to
its lowest level since April 2018.

The dollar index rose 0.169%, with the euro up
0.88% to $1.2244.

The Japanese yen strengthened 0.08% versus the greenback to
103.12 per dollar, while Sterling was last trading at
$1.3556, down 0.84% on the day.

Gold prices were up more than 2%, while U.S. crude
futures fell 1.9% to settle at $47.62 a barrel and Brent
futures dropped 1.4% to $51.09.

U.S. Treasury yields edged higher as traders repositioned at
the start of trading in the new year. Benchmark 10-year Treasury
notes last fell 1/32 in price to yield 0.9148%.

(Additional reporting by Ritvik Carvalho in London and by Medha
Singh and Shivani Kumaresan in Bengaluru; Editing by Toby
Chopra, Dan Grebler and Paul Simao)

More News
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:53

LONDON MARKET OPEN: FTSE 100 opens higher ahead of US CPI

(Alliance News) - Stock prices in London opened higher on Tuesday, as investors digest the latest UK unemployment data, before turning their eyes to US inflation this afternoon.

Read more
12 Dec 2023 08:37

AstraZeneca acquires vaccine developer Icosavax for USD1.1 billion

(Alliance News) - AstraZeneca PLC confirmed on Tuesday that it will buy Icosavax Inc, boosting its vaccine portfolio with an "innovative" treatment for respiratory viruses.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:16

AstraZeneca to buy US vaccine maker Icosavax for up to $1.1bn

(Sharecast News) - AstraZeneca said on Tuesday that it has agreed to buy Icosavax - a US-based clinical-stage biopharmaceutical company - for up to $1.1bn.

Read more
12 Dec 2023 02:00

UK companies pause China investment decisions as economy slows, survey shows

BEIJING, Dec 12 (Reuters) - A slowdown in both the Chinese and global economies is the biggest issue affecting British firms in the world's second-largest economy, beating geopolitical concerns and market access barriers, according to the British Chamber of Commerce in China.

Read more
11 Dec 2023 08:15

AstraZeneca says danicopan tests well as blood disorder treatment

(Alliance News) - AstraZeneca PLC on Monday reported "positive results" from a test of danicopan for the treatment of paroxysmal nocturnal haemoglobinuria, or PNH, a rare and severe blood disorder.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
1 Dec 2023 08:52

LONDON MARKET OPEN: Miners give FTSE 100 boost thanks to China PMI

(Alliance News) - Stock prices in London opened higher on Friday, with the FTSE 100 boosted by mining stocks.

Read more
1 Dec 2023 08:33

AstraZeneca discontinues two phase III evidence trials for Lokelma

(Alliance News) - AstraZeneca on Friday said it has decided to discontinue the Stabilize-CKD and Dialize-outcomes phase III trials for Lokelma, citing increased enrolment timelines.

Read more
1 Dec 2023 08:01

AstraZeneca calls off two phase III trials into hyperkalaemia treatment

(Sharecast News) - Drugmaker AstraZeneca has called off two phase III trials on its hyperkalaemia treatment after a series of logistical challenges.

Read more
1 Dec 2023 07:41

LONDON BRIEFING: Stocks called higher; UK house prices fall annually

(Alliance News) - Stocks in London are called to open higher on Friday, following data from Nationwide showing that the annual pace of UK house price decline slowed in November.

Read more
27 Nov 2023 16:12

London close: Stocks start week in subdued state

(Sharecast News) - London's financial markets saw a somewhat subdued performance on Monday, as concerns regarding the Chinese economy cast a shadow over investor sentiment.

Read more
27 Nov 2023 09:20

LONDON BROKER RATINGS: Peel, Numis up Rightmove; Goldman cuts Entain

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
23 Nov 2023 18:41

IN BRIEF: AstraZeneca Chair Demare buys shares for over GBP200,000

AstraZeneca PLC - Cambridge-based pharmaceutical company - Chair Michel Demare buys 2,000 shares in total on Wednesday and Tuesday. Buys 1,000 shares for GBP101.05 each on Tuesday and 1,000 shares for GBP101.70 each on Thursday, for a total of GBP202,752.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.